Free Live Training
Breakthrough stem cell technology for chronic conditions, and why Regen MDs reports a 90%+ success rate* among patients who complete the full 4 month at-home protocol
Two board-certified physicians break down what has actually changed in regenerative medicine, why the newest protocols are cell-free rather than cell-based, and how patients living with chronic conditions are completing the entire 4 month program from home. No clinic. No travel. No surgery.
Your 90 minutes, mapped out.
One session, four parts, then live Q&A. Here is exactly what gets covered and when.
Why chronic conditions stop responding to conventional care
- Where medication, symptom management and conventional treatment genuinely help, and where each one tends to plateau.
- Why so many patients with chronic conditions cycle through specialists for years without getting a clear answer.
- What changes when you stop treating the symptom and start looking at the body's signaling environment instead.
The breakthrough: what actually changed in stem cell technology
- Why the field moved away from delivering living cells and toward delivering the signals those cells produce.
- What RSF Pro is, and why cell-free, DNA-free and RNA-free is the entire point rather than a technicality.
- Why it draws signaling factors from six placental regions instead of a single source, and what that changes.
- How all of this differs from what most people picture when they hear the words “stem cell therapy.”
Real patients with chronic conditions, in their own words
- Walkthroughs of real Regen MDs patients and what their protocol actually looked like month to month.
- Honest talk about who this approach is not the right fit for, and the cases we decline.
- What our physicians weigh when they review an application.
The 4 month at-home protocol, start to finish
- Physician evaluation, personalized plan, and guided in-home treatment.
- Ongoing telehealth monitoring, and how the plan adjusts as you progress.
- Then live Q&A: bring your questions about your own condition and get them answered on the call.
Real patients. Real experiences.
Every one of them started where you are now, looking into an option they had never heard explained properly.
What, when, and where.
A 100% free live training on the breakthrough in stem cell technology and how it applies to chronic conditions. Two regenerative medicine physicians explain it in plain English, then answer your questions live.
Wednesday, September 16 at 7:00 PM EST. Approximately 90 minutes, including the live Q&A block at the end.
Hosted online, join from anywhere. Your link arrives by email and text. A replay goes out to registrants afterward.
90 minutes that could change how you understand your options.
What Actually Changed
The shift from delivering living cells to delivering the signals themselves, and why that shift is what makes an at-home protocol possible in the first place.
Why Cell-Free Is The Point
What cell-free, DNA-free and RNA-free actually mean for a patient, explained in language that doesn't require a biology degree.
The Six-Region Difference
Why RSF Pro sources signaling factors from six distinct placental regions rather than one, and what that changes about the protocol.
Treatment Without Travel
How the entire 4 month protocol is guided from your home through telehealth, instead of flying overseas to a clinic.
Who Actually Qualifies
The factors our physicians weigh on every application, and an honest account of which chronic conditions we turn away and why.
Your Questions, Answered Live
The session closes with open Q&A. Ask about your own condition and get a straight answer from a physician.
Two physicians, one protocol.
Dr. Greg Carder
Dr. Carder reviews patient applications personally and leads the clinical side of the Regen MDs protocol. On the training he walks through the science behind the breakthrough, and what separates signaling-first regenerative medicine from the stem cell therapies most chronic condition patients have already looked into.
Dr. Mick Emandi
Dr. Emandi leads Regen MDs and built the at-home care model that lets patients complete the full protocol without traveling. He covers candidacy, what the 4 month program involves week to week, and takes questions live on the call.
Seats are limited so every question gets answered.
Breakthrough Stem Cell Technology for Chronic Conditions. Free and live on Wednesday, September 16 at 7:00 PM EST. Your access link is sent to your email and phone the moment you register.
© 2026 Regen MDs. All rights reserved.
*About the 90%+ Figure: The 90%+ success rate referenced on this page reflects internal clinical observations of patients who completed the full 4 month Regen MDs protocol as directed, where success was defined as patient-reported improvement in their primary complaint. This figure is based on clinical observation, not a randomized controlled clinical trial, and it has not been independently verified. It is not a guarantee or prediction of your results. Individual results vary, and some patients experience little or no improvement.
Testimonials: Patients appearing on this page are describing their own experience. Individual results vary and are not a guarantee of outcome. Like all medical procedures, regenerative therapies have a success and failure rate.
Medical Disclaimer: The information on this page and in the training is provided for general informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease, and it is not a substitute for advice from your own physician. Candidacy is determined by a licensed physician, every applicant is reviewed individually, and we only move forward with patients we believe we can genuinely help. Regenerative and cellular therapies have not been approved by the FDA for the treatment of any specific disease or condition. Statements on this page have not been evaluated by the Food and Drug Administration.
This site is not a part of the Facebook website or Meta Platforms, Inc. Additionally, this site is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of Meta Platforms, Inc.